These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
773 related items for PubMed ID: 9521470
21. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases. Hull D, Ma J, Singh H, Hossain D, Qian J, Bostwick DG. BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995 [Abstract] [Full Text] [Related]
22. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate. Rekhi B, Jaswal TS, Arora B. Indian J Cancer; 2004 Oct; 41(2):60-5. PubMed ID: 15318010 [Abstract] [Full Text] [Related]
23. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Patton KT, Chen HM, Joseph L, Yang XJ. Histopathology; 2005 Dec; 47(6):597-601. PubMed ID: 16324197 [Abstract] [Full Text] [Related]
24. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Festuccia C, Angelucci A, Gravina GL, Muzi P, Miano R, Vicentini C, Bologna M. Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728 [Abstract] [Full Text] [Related]
25. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Morote J, Fernández S, Alaña L, Iglesias C, Planas J, Reventós J, Ramón Y Cajal S, Paciucci R, de Torres IM. Clin Cancer Res; 2008 May 01; 14(9):2617-22. PubMed ID: 18451224 [Abstract] [Full Text] [Related]
26. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Nägler DK, Krüger S, Kellner A, Ziomek E, Menard R, Buhtz P, Krams M, Roessner A, Kellner U. Prostate; 2004 Jul 01; 60(2):109-19. PubMed ID: 15162377 [Abstract] [Full Text] [Related]
27. Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation. Iemelynova AA, Grygorenko VM, Cheremuha SV, Romanenko AM. Exp Oncol; 2009 Dec 01; 31(4):246-9. PubMed ID: 20010526 [Abstract] [Full Text] [Related]
28. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F, Epstein JI. Am J Surg Pathol; 2008 Jul 01; 32(7):1060-7. PubMed ID: 18496142 [Abstract] [Full Text] [Related]
29. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma. Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW. Cancer; 2002 Dec 15; 95(12):2487-93. PubMed ID: 12467061 [Abstract] [Full Text] [Related]
30. p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma. Hughes JH, Cohen MB, Robinson RA. Mod Pathol; 1995 Jun 15; 8(5):462-6. PubMed ID: 7675761 [Abstract] [Full Text] [Related]
31. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG. Cancer Epidemiol Biomarkers Prev; 1998 Jun 15; 7(6):531-6. PubMed ID: 9641498 [Abstract] [Full Text] [Related]
32. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J, Bostwick DG. Exp Mol Pathol; 2004 Oct 15; 77(2):153-9. PubMed ID: 15351240 [Abstract] [Full Text] [Related]
33. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Maygarden SJ, Strom S, Ware JL. Arch Pathol Lab Med; 1992 Mar 15; 116(3):269-73. PubMed ID: 1371380 [Abstract] [Full Text] [Related]
34. Biologic markers in prostatic intraepithelial neoplasia: immunohistochemical and cytogenetic analyses. Tsuji M, Kanda K, Murakami Y, Kurokawa Y, Kanayama H, Sano T, Kagawa S. J Med Invest; 1999 Feb 15; 46(1-2):35-41. PubMed ID: 10408155 [Abstract] [Full Text] [Related]
35. Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression? Xue Y, Smedts F, Latijnhouwers MA, Ruijter ET, Aalders TW, de la Rosette JJ, Debruyne FM, Schalken JA. Anticancer Res; 1998 Feb 15; 18(4A):2679-84. PubMed ID: 9703928 [Abstract] [Full Text] [Related]
36. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. Shibata MA, Ward JM, Devor DE, Liu ML, Green JE. Cancer Res; 1996 Nov 01; 56(21):4894-903. PubMed ID: 8895741 [Abstract] [Full Text] [Related]
37. Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. Wiley EL, Davidson P, McIntire DD, Sagalowsky AI. Urology; 1997 May 01; 49(5):692-6. PubMed ID: 9145972 [Abstract] [Full Text] [Related]
38. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Qian J, Jenkins RB, Bostwick DG. Mod Pathol; 1997 Nov 01; 10(11):1113-9. PubMed ID: 9388062 [Abstract] [Full Text] [Related]
39. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Montironi R, Lucarini G, Castaldini C, Galluzzi CM, Biagini G, Fabris G. Anticancer Res; 1996 Nov 01; 16(4A):2057-62. PubMed ID: 8712742 [Abstract] [Full Text] [Related]
40. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F, Jenkins RB, Bieberich CJ, De Marzo AM. Cancer Res; 2006 Nov 15; 66(22):10683-90. PubMed ID: 17108105 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]